ReviewAnnual review of vision science2026
Schlemm's Canal Development and Implications for Glaucoma Treatment.
Review in Annual review of vision science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The Schlemm's canal (SC) is located in the iridocorneal angle of the eye and is critical for regulating intraocular pressure, a contributing factor to glaucoma. SC endothelial cells create the final barrier to aqueous humor (AH) drainage from the eye. SC morphogenesis occurs through a process known as canalogenesis, which combines features of blood vascular and lymphatic development. This reflects the combined lymphatic and blood vascular features of the adult SC. SC development is closely coordinated with the formation of the trabecular meshwork, an adjacent drainage tissue in the angle. Developmental disorders of the SC and trabecular meshwork cause impaired AH drainage, elevated intraocular pressure, and glaucoma. The mechanisms by which the SC develops and controls AH drainage remain partially understood. Recent studies, including single-cell sequencing approaches, are transforming our understanding of the SC, its development, and the genes involved in glaucoma. We highlight current knowledge of SC development, functional morphology, AH drainage past SC endothelial cells, and implications for novel glaucoma treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.